2019
DOI: 10.1016/j.cellsig.2018.11.015
|View full text |Cite
|
Sign up to set email alerts
|

A novel Rhein derivative: Activation of Rac1/NADPH pathway enhances sensitivity of nasopharyngeal carcinoma cells to radiotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
10
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 21 publications
(11 citation statements)
references
References 31 publications
1
10
0
Order By: Relevance
“…The CNE1 and CNE2 were the first and second strains established by the Chinese Academy of Preventive Medicine and have been widely used in various researches. The differentiation characteristics have also been confirmed by other report [19]. In this study, these cell lines were commercially purchased from the company (Taisheng Biotech., Guangzhou, China) and cultured in RPMI-1640 medium supplemented with 100 U/mL streptomycin, 100 U/mL penicillin, and 10% Newborn Calf Serum (Invitrogen Corporation, USA).…”
Section: Methodssupporting
confidence: 78%
“…The CNE1 and CNE2 were the first and second strains established by the Chinese Academy of Preventive Medicine and have been widely used in various researches. The differentiation characteristics have also been confirmed by other report [19]. In this study, these cell lines were commercially purchased from the company (Taisheng Biotech., Guangzhou, China) and cultured in RPMI-1640 medium supplemented with 100 U/mL streptomycin, 100 U/mL penicillin, and 10% Newborn Calf Serum (Invitrogen Corporation, USA).…”
Section: Methodssupporting
confidence: 78%
“…Similarly, Rac1 also affects the sensitivity of cancer to radiotherapy. RP-4, a new type of radiosensitizer derived from rhein, activates the sensitivity of nasopharyngeal carcinoma (NPC) cells to radiotherapy by targeting the Rac1-NADPH pathway (149). Our research team has confirmed that Rac1 can target the PAK1-LIMK1-Cofilins signaling pathway to cause radiotherapy resistance in lung cancer (150).…”
Section: Rac1 Is Involved In the Regulation Of Resistance To Tumor Therapymentioning
confidence: 74%
“…One target of Rac1 during DNA-damage and induction of apoptosis is JNK 14–18 . The Rac1/JNK pathway has been involved in doxorubicin-induced apoptosis of cardiomyocytes and human cancer cells 18,32,33 . Previously, we found in T-ALL cells that doxorubicin-induced JNK activity promoted apoptosis by downregulating the levels of anti-apoptotic protein Mcl-1, and collagen inhibited JNK activation and restored Mcl-1 levels 6 .…”
Section: Resultsmentioning
confidence: 99%